Biological E to tender final data on Corbevax COVID vaccine by November end

Pharmaceutical company Biological E on October 14 stated that it will submit data of its COVID vaccine Corbevax till vember end. pharma company h recently sought consent from drug regulator, Drugs Controller General (DGCI) of India to initiate phase-3 clinical trial of COVID vaccine Corbevax till vember end. company has sought approval for a single booster dose for those fully vaccinated with Covishield or Covaxin COVID vaccines.

Corbevax is one of largest vaccine makers indigeusly in India against COVID virus. Or major vaccines me in India are Covaxin, manufactured by Bharat Biotech, and ZyCOV-D by Zydus Cila. Corbevax is a protein subunit vaccine. government h earlier anunced supply of about 30 Crore doses of Corbevax by December this year.

Earlier on September 02, NITI Aayog member (Health) VK Paul h informed that Hyderab-based pharma company is expected to launch its vaccine against Coronavirus in October this year. Paul h said that Phase III of Biological E's trial is underway. "Stockpile is being produced. We should wait for results. We hope it will be in next month or two. y have me a bro commitment that y will supply a significant amount by year-end."

DGCI gives d for clinical trial on children 

DGCI on Wednesday, September 13, granted company permission to conduct phase II/III clinical trials of Me in India vaccine for children of group 5-18 years on certain conditions. government has me an vance payment of Rs 1,500 crore to Biological E for 30 crore vaccines.  

Corbevax is based on a protein antigen techlogy that binds to Angiotensin-Converting Enzymes-2 (ACE2) receptor on host cell membrane and facilities entry of virus. body's cell stimulates immune system of body to produce antibodies to make a shield against lethal virus.

India COVID report

Meanwhile, India on Thursday registered 18,987 fresh cases of COVID disease taking infection tally to 3,40,20,730, while national COVID recovery rate increased to 98.07%, according to data circulated by Union Health Ministry.
Meanwhile, death toll climbed to 4,51,435 with 246 fresh fatalities. daily rise in fresh coronavirus infections has been below count of 30,000 for 20 straight days and less than 50,000 daily new cases have been registered for 109 consecutive days w.

(With Inputs from ANI)

Im: AP